Development of Fibrotic Penile Lesions Secondary to the Intracorporeal Injection of Vasoactive Agents
- 1 September 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 140 (3) , 615-617
- https://doi.org/10.1016/s0022-5347(17)41738-1
Abstract
Fibrotic penile lesions developed in 4 patients who had undergone intracorporeal injection of vasoactive agents. These lesions persisted for at least 3 months, and in some instances they caused pain and curvature of the penis during erection.This publication has 8 references indexed in Scilit:
- Fibrosis of Corpus Cavernosum After Intracavernous Injection of Phentolamine/PapaverineJournal of Urology, 1987
- Intracorporal Injection of Papaverine and Phentolamine in the Management of ImpotenceBritish Journal of Urology, 1986
- Papaverine-Induced Priapism: 2 Case ReportsJournal of Urology, 1986
- Priapism: A Refined Approach to Diagnosis and TreatmentJournal of Urology, 1986
- Diagnostic Tests for Impotence: A Comparison of Papaverine Injection with the Penile-Brachial Index and Nocturnal Penile Tumescence MonitoringJournal of Urology, 1986
- Intracavernous Drug-Induced Erections in the Management of Male Erectile Dysfunction: Experience with 100 PatientsJournal of Urology, 1986
- Auto-Injection of the Corpus Cavernosum with a Vasoactive Drug Combination for Vasculogenic ImpotenceJournal of Urology, 1985
- Cavernosal Alpha-Blockade: A New Technique for Investigating and Treating Erectile ImpotenceThe British Journal of Psychiatry, 1983